OPKO Health logo
OPKO Health OPK
€ 1.18 0.0%

Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025

report update icon

OPKO Health Langfristiger Schuldenstrom 2011-2026 | OPK

Langfristiger Schuldenstrom Jährlich OPKO Health

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
12.6 M 13 M 11.6 M 11.6 M 9.03 M 12 M - 11.9 M 12 M 11.5 M 13.5 M 12.6 M - 8.76 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
13.5 M 8.76 M 11.7 M

Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Centogene N.V. Centogene N.V.
CNTG
2.18 M - -6.23 % $ 30.6 M germanyGermany
Brainsway Ltd. Brainsway Ltd.
BWAY
824 K $ 22.95 -0.61 % $ 99.4 M israelIsrael
Akumin Akumin
AKU
17.2 M - -17.87 % $ 25.9 M canadaCanada
Accelerate Diagnostics Accelerate Diagnostics
AXDX
829 K - -61.36 % $ 2.46 M usaUSA
Danaher Corporation Danaher Corporation
DHR
173 M $ 237.39 1.0 % $ 174 B usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
111 K $ 12.34 -4.38 % $ 350 M israelIsrael
Biocept Biocept
BIOC
518 K - -13.05 % $ 7.29 M usaUSA
DexCom DexCom
DXCM
21.1 M $ 67.58 -1.23 % $ 26.1 B usaUSA
BioNano Genomics BioNano Genomics
BNGO
2.99 M $ 1.59 -0.94 % $ 2.02 M usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
915 K - 0.22 % $ 16.8 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
264 K - - $ 9.42 M israelIsrael
Co-Diagnostics Co-Diagnostics
CODX
838 K $ 6.03 -1.45 % $ 177 M usaUSA
IQVIA Holdings IQVIA Holdings
IQV
99 M $ 244.83 0.69 % $ 44.4 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
1.66 M $ 38.99 -2.26 % $ 1.08 B usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
147 K - - $ 399 M chinaChina
DermTech DermTech
DMTK
3.07 M - -11.32 % $ 2.94 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
264 K - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
21.5 M - 0.12 % $ 80.1 M chinaChina
Natera Natera
NTRA
7.64 M $ 233.95 -2.34 % $ 23 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
5.94 M $ 17.16 -0.38 % $ 923 M usaUSA
Celcuity Celcuity
CELC
172 K $ 104.35 -0.31 % $ 4.12 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
841 K - -8.98 % $ 14.8 K usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
29 K $ 3.38 -1.17 % $ 108 K usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
27.4 M $ 102.12 0.33 % $ 18.9 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
9.59 M $ 1.97 -3.43 % $ 500 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
1.44 M $ 27.9 0.02 % $ 844 M usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
23.4 M $ 48.36 -0.19 % $ 10.8 B niderlandNiderland
RadNet RadNet
RDNT
56.6 M $ 78.45 0.09 % $ 5.73 B usaUSA
Guardant Health Guardant Health
GH
29.2 M $ 108.76 0.02 % $ 13.3 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
77 K - -6.19 % $ 10.5 M usaUSA
Heska Corporation Heska Corporation
HSKA
2.94 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
475 K - -20.0 % $ 1.06 M usaUSA
Illumina Illumina
ILMN
79 M $ 141.31 -3.1 % $ 22.5 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
54.2 M $ 221.27 2.64 % $ 11.4 B usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
261 M $ 617.5 1.81 % $ 236 B usaUSA
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
13.8 M $ 35.42 1.96 % $ 2.12 B usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
173 M $ 176.09 -0.96 % $ 19.5 B usaUSA
Biodesix Biodesix
BDSX
719 K $ 5.36 -4.11 % $ 695 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
185 M $ 254.43 -0.1 % $ 21.3 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
24.3 M $ 184.65 -1.9 % $ 15.2 B irlandaIrlanda
IDEXX Laboratories IDEXX Laboratories
IDXX
21.5 M $ 714.6 0.31 % $ 58.9 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
1.87 M $ 67.0 -1.25 % $ 4.64 B usaUSA
Biomerica Biomerica
BMRA
358 K $ 2.7 -6.57 % $ 6.2 M usaUSA
Bioventus Bioventus
BVS
4.06 M $ 7.86 -1.75 % $ 492 M usaUSA